NucleoBio

July 9, 2018

Prostreat Seen as Better Than Current Therapies at Stopping Aggressive Prostate Cancer in Mice

News

NucleoBio’s investigative therapy Prostreat was seen to be better at preventing the growth and spread of metastatic castration-resistant prostate cancer than currently available hormone therapies, a mouse study showed. The ... Read more

May 9, 2018

NucleBio’s New Prostac Test May Improve Diagnosis of Aggressive Prostate Cancer, Company Says

News

A new test called Prostac is able to accurately tell the difference between benign and aggressive prostate cancer, which has the potential to significantly improve men’s healthcare, according to developer NucleoBio. “Prostac ... Read more